The only way out is in: a deeper understanding of anti-VEGF therapy escape mechanisms offers possibilities for more effective antiangiogenic treatment. - Suppr | 超能文献

The only way out is in: a deeper understanding of anti-VEGF therapy escape mechanisms offers possibilities for more effective antiangiogenic treatment.

作者信息

Ottenhausen Malte, Bodhinayake Imithri, Boockvar John A

出版信息

Neurosurgery. 2013 Dec;73(6):N9. doi: 10.1227/NEU.0000000000000210.

DOI:10.1227/NEU.0000000000000210

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The only way out is in: a deeper understanding of anti-VEGF therapy escape mechanisms offers possibilities for more effective antiangiogenic treatment.

Neurosurgery. 2013 Dec;73(6):N9. doi: 10.1227/NEU.0000000000000210.

2

Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.胶质母细胞瘤血管生成：VEGF 耐药解决方案和基于肿瘤血管形成分子机制的新策略。

Brain Tumor Pathol. 2012 Apr;29(2):73-86. doi: 10.1007/s10014-011-0077-6. Epub 2012 Jan 6.

3

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited.用血管内皮生长因子抑制剂抑制或促进转移：重新审视抗血管生成

Cancer Cell. 2009 Mar 3;15(3):167-70. doi: 10.1016/j.ccr.2009.02.007.

4

Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.作为一种补偿抗 VEGF 治疗耐药性的策略的抗 FGF2 方法：长五聚蛋白 3 作为一种新型的抗血管生成 FGF2 拮抗剂。

Eur Cytokine Netw. 2009 Dec;20(4):225-34. doi: 10.1684/ecn.2009.0175.

5

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.抗血管内皮生长因子治疗期间胶质母细胞瘤耐药性和侵袭的介质。

Clin Cancer Res. 2009 Jul 15;15(14):4589-99. doi: 10.1158/1078-0432.CCR-09-0575. Epub 2009 Jun 30.

6

Mechanisms of resistance to antiangiogenesis therapy.抗血管生成治疗的耐药机制。

Eur J Cancer. 2010 May;46(8):1323-32. doi: 10.1016/j.ejca.2010.02.020. Epub 2010 Mar 17.

7

Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.微环境在肿瘤生长以及对抗血管生成疗法的难治性/抗性中的作用。

Drug Resist Updat. 2008 Dec;11(6):219-30. doi: 10.1016/j.drup.2008.09.001. Epub 2008 Oct 23.

8

Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.介导对血管内皮生长因子靶向治疗耐药的途径。

Clin Cancer Res. 2008 Oct 15;14(20):6371-5. doi: 10.1158/1078-0432.CCR-07-5287.

9

Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.PJ-8，一种新型血管内皮生长因子受体信号抑制剂的抗血管生成机制。

Carcinogenesis. 2012 May;33(5):1022-30. doi: 10.1093/carcin/bgs127. Epub 2012 Mar 20.

10

Mechanisms of resistance to vascular endothelial growth factor blockade.血管内皮生长因子阻断治疗的耐药机制。

Cancer. 2012 Jul 15;118(14):3455-67. doi: 10.1002/cncr.26540. Epub 2011 Nov 15.

引用本文的文献

1

Therapeutic effects of LS-13 on glioma in vivo and in vitro.LS-13对胶质瘤的体内外治疗效果。

CNS Neurosci Ther. 2014 Oct;20(10):947-9. doi: 10.1111/cns.12320. Epub 2014 Aug 28.